中文 | English
Return
Total: 175 , 1/18
Show Home Prev Next End page: GO
MeSH:(Prostatic Neoplasms/genetics/*pathology)

1.Relationship between TMPRSS2: ERG and the pathological grade of prostate cancer.

Fa-xian YI ; Hong LI ; Qiang WEI ; Xiang LI ; Hao ZENG

National Journal of Andrology 2015;21(10):887-891

2.The regulatory pathways leading to stem-like cells underlie prostate cancer progression.

Chun-Jung LIN ; U-Ging LO ; Jer-Tsong HSIEH

Asian Journal of Andrology 2019;21(3):233-240

3.Androgen receptor mutation and progression of prostate cancer.

Jian-Guo MA ; Wen-Ping LI ; Yu-Qing JIANG

National Journal of Andrology 2011;17(7):649-654

4.Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer.

Hanqing ZENG ; Yajun XIAO ; Gongchen LU ; Yong CHEN

Journal of Huazhong University of Science and Technology (Medical Sciences) 2003;23(4):373-379

6.Progress in the studies of prostate cancer related molecules.

Wei SHI ; Li DONG ; Jun-sheng BAO

National Journal of Andrology 2015;21(4):357-362

8.Clinical significance of six-transmembrane epithelial antigen of the prostate expressed in prostatic carcinoma.

Liaoyuan LI ; Jiefang LI ; Zhoujun SHEN ; Weijun LIU ; Zhaodian CHEN

National Journal of Andrology 2004;10(5):351-354

9.Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials.

Anping, SONG ; Guoning, LIAO ; Mingfu, WU ; Yunping, LU ; Ding, MA

Journal of Huazhong University of Science and Technology (Medical Sciences) 2007;27(5):582-5

10.MiR-124 suppresses the proliferation of human prostate cancer PC3 cells by targeting PKM2.

Lei LÜ ; Jing-Dong YUAN ; Zuo-Liang CAO ; Tao HUANG ; Chuan-Hua ZHANG ; Liang WANG ; Fu-Qing ZENG

National Journal of Andrology 2014;20(6):495-499

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 175 , 1/18 Show Home Prev Next End page: GO